Neoadjuvant and adjuvant toripalimab for high-risk locoregionally advanced nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled phase 2 trial

被引：0
|
作者：
Liu, Sai Lan
Mai, Hai-Qiang
Wen, Dongxiang
Yang, Jin-Hao
Guo, Shan-Shan
Liu, Li-Ting
Luo, Mei-Juan
Liang, YuJing
Sun, Xue-Song
Li, Xiao-Yun
Luo, Dong-Hua
Li, Ji-Bin
Wang, Pan
Guo, Ling
Mo, Hao-Yuan
Sun, Rui
Zhao, Chong
Xu, Rui-Hua
Tang, Lin-Quan
Chen, Qiu-Yan
机构：
[1] Sun Yat sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat sen Univ, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med,Canc Ctr, State Key Lab Oncol South China,Guangdong Key Lab, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Clin Trials Ctr, Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat sen Univ, Sun Yat sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tislelizumab versus placebo combined with induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant tislelizumab or placebo for locoregionally advanced nasopharyngeal carcinoma: Interim analysis of a multicenter, randomized, placebo-controlled, double-blind, phase 3 trial.
    Mai, Hai-Qiang
    Liu, Sai Lan
    Chen, Qiu-Yan
    Tang, Lin-Quan
    Jin, Feng
    Guo, Ling
    Luo, Haiqing
    Hu, Ying
    Liu, Huai
    Liang, Jin-Hui
    Zhao, Chong
    Luo, Dong-Hua
    Mo, Hao-Yuan
    Guo, Shan-Shan
    Liu, Li-Ting
    Li, Ji-Bin
    Wang, Lin
    Sun, Xue-Song
    Li, Xiao-Yun
    Wang, Pan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FISH-OIL IN HIGH-RISK PREGNANCY
    ONWUDE, JL
    LILFORD, JR
    HJARTARDOTTIR, H
    STAINES, A
    TUFFNELL, D
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (02): : 95 - 100
  • [3] Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial
    Mahdavinasab, Seyedeh-Mahsa
    Saghazadeh, Amene
    Motamed-Gorji, Nogol
    Vaseghi, Salar
    Mohammadi, Mohammad-Reza
    Alichani, Rosa
    Akhondzadeh, Shahin
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2019, 28 (12) : 1619 - 1628
  • [4] Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial
    Seyedeh-Mahsa Mahdavinasab
    Amene Saghazadeh
    Nogol Motamed-Gorji
    Salar Vaseghi
    Mohammad-Reza Mohammadi
    Rosa Alichani
    Shahin Akhondzadeh
    European Child & Adolescent Psychiatry, 2019, 28 : 1619 - 1628
  • [5] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [6] Adjuvant capecitabine in locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized controlled phase III trial.
    Miao, Jingjing
    Wang, Lin
    Tan, Sze Huey
    Li, Jin-Gao
    Yi, Junlin
    Zhang, Ye
    Gong, Xiaochang
    Xiang Yanqun
    Chen, Qiu-Yan
    Chen, Mingyuan
    Lv, Xing
    Xia, Weixiong
    Tang, Lin-Quan
    Deng, Xiao-Wu
    Guo, Xiang
    Mai, Hai-Qiang
    Han, Fei
    Chua, Melvin Lee Kiang
    Zhao, Chong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
    Tufan, Ayse N.
    Tufan, Fatih
    NEUROLOGY, 2015, 85 (23) : 2083 - 2084
  • [8] Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial
    Culp, Stephen H.
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2009, 55 (06) : 1484 - 1485
  • [9] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
    Butchart, Joseph
    Brook, Laura
    Hopkins, Vivienne
    Teeling, Jessica
    Puentener, Ursula
    Culliford, David
    Sharples, Richard
    Sharif, Saif
    McFarlane, Brady
    Raybould, Rachel
    Thomas, Rhodri
    Passmore, Peter
    Perry, V. Hugh
    Holmes, Clive
    NEUROLOGY, 2015, 84 (21) : 2161 - 2168
  • [10] Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
    Park, S.
    Sun, J-M
    Choi, Y-L
    Oh, D.
    Kim, H. K.
    Lee, T.
    Chi, S. A.
    Lee, S-H
    Choi, Y. S.
    Jung, S-H
    Ahn, M-J
    Ahn, Y. C.
    Park, K.
    Shim, Y. M.
    ESMO OPEN, 2022, 7 (01)
12345